Health Condition 1: N944- Primary dysmenorrhea
Conditions
Interventions
None listed
Sponsors
Central Council for Research in Ayurvedic Sciences CCRAS
Eligibility
Inclusion criteria
Inclusion criteria: i.Young women of age 18 -25 years of scheduled Caste community ii.Self-reported history consistent with primary dysmenorrheal of moderate to severe nature (Mild: doesnâ??t interfere in normal activities, Moderate: slightly interferes in daily routines but can be managed by painkillers, Severe: markedly prevents daily life activities) with a self-reported menstrual cycle of averaging 21-35 days. iii.Willing and able to participate in the study (Written informed consent or assent).
Exclusion criteria
Exclusion criteria: i.Irregular Cycles. ii.Cases of secondary Dysmenorrhea iii.Pain abdomen associated with excessive bleeding per vagina. iv.Presence of persistent pelvic pain throughout the menstrual cycle. v.Known case / diagnosis /h/o of leiomyoma of uterus, ovarian cyst, endometriosis. vi.Associated with clinically diagnosed pelvic inflammatory disease (PID), vii.Associated with any pre-diagnosed or clinically diagnosed systemic disorders likely to influence menstrual cycle. viii.Patients with Hb ix.History of malignancy of pelvic organs. x.Diagnosed cases Hypo/hyperthyroidism . xi.Woman using IUD / Oral Contraceptive Pills (OCP) xii.Patient co morbid with systemic diseases like diabetes mellitus, hypertension, cardiac/ Renal/ Pulmonary/ Hepatic disorders. xiii.Women who are planning to conceive in the next 6 months. xiv.Participation in other concomitant therapy for acute or chronic pain.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i.Change in Visual Analog Scale (VAS) for pain.Timepoint: At baseline, after 1 month, after 2 months, after 3 months and after 4 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| i.Changes in total WaLLID score. ii.Change in Hb status of the subject from the baseline to the end of trial -12 weeks. iii.Decrease in the use of Analgesic medication (dosage & frequency of medication used) Timepoint: [Time Frame: Assessed via questionnaire after every menstrual cycle for four cycles] | — |
Countries
India
Contacts
Public ContactCHRIS ANTONY
Regional Ayurveda Research Institute CCRAS Mandi Himachal Pradesh
Outcome results
None listed